CANDEL THERAPEUTICS, INC. (CADL) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$26.75M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$16.28M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$13.21M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$11.18M; Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2020-12-31 to 2023-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | (m) | -$26.75M | (m) | (m) | (m) | $69.00K* | -$17.18M* | (m) | $19.80M | (m) | (m) |
|---|
| 2026-03-31 | Reported | (m) | -$16.28M | (m) | (m) | (m) | $675.00K | -$18.04M | (m) | $9.84M | (m) | (m) |
|---|
| 2025-09-30 | Reported | (m) | -$13.21M | (m) | (m) | (m) | $144.00K* | -$10.24M* | (m) | $8.46M | (m) | (m) |
|---|
| 2025-06-30 | Reported | (m) | -$11.18M | (m) | (m) | (m) | $31.00K* | -$8.89M* | (m) | $6.99M | (m) | (m) |
|---|
| 2025-03-31 | Reported | (m) | -$8.13M | (m) | (m) | (m) | $3.00K | -$8.62M | (m) | $4.02M | (m) | (m) |
|---|
| 2024-09-30 | Reported | (m) | -$8.76M | (m) | (m) | (m) | $0.00* | -$6.57M* | (m) | $5.42M | (m) | (m) |
|---|
| 2024-06-30 | Reported | (m) | -$8.57M | (m) | (m) | (m) | $6.00K* | -$6.20M* | (m) | $4.98M | (m) | (m) |
|---|
| 2024-03-31 | Reported | (m) | -$7.90M | (m) | (m) | (m) | $7.00K | -$8.44M | (m) | $4.10M | (m) | (m) |
|---|
| 2023-09-30 | Reported | (m) | -$8.86M | (m) | (m) | (m) | $103.00K* | -$8.81M* | (m) | $5.84M | (m) | $0.00* |
|---|
| 2023-06-30 | Reported | -$9.34M* | -$9.58M | $236.00K* | (m) | (m) | $169.00K* | -$7.20M* | (m) | $5.93M | (m) | $0.00* |
|---|
| 2023-03-31 | Reported | -$9.4M | (m) | (m) | (m) | (m) | $138.00K | -$10.82M | (m) | $5.47M | (m) | $0.00 |
|---|
| 2022-12-31 | Reported | -$7.88M | (m) | (m) | (m) | -25419.35% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$8.68M* | -$8.88M | $205.00K* | $31.00K | -27987.10%* | $215.00K* | -$9.38M* | (m) | $5.38M | (m) | $0.00 |
|---|
| 2022-06-30 | Reported | -$8.57M* | -$8.75M | $187.00K* | $31.00K | -27632.26%* | $635.00K* | -$7.10M* | (m) | $5.02M | (m) | $0.00* |
|---|
| 2022-03-31 | Reported | -$8.82M | (m) | (m) | (m) | -28454.84% | $171.00K | -$8.05M | (m) | $5.42M | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | -$7.56M | (m) | (m) | (m) | -24393.55% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$8.01M* | -$8.03M | $21.00K* | $31.00K | -25832.26%* | $392.00K* | -$6.89M* | (m) | $5.26M | (m) | $0.00 |
|---|
| 2021-06-30 | Reported | -$5.29M* | -$5.30M | $7.00K* | $31.00K | -17077.42%* | $710.00K* | -$4.46M* | (m) | $3.29M | (m) | (m) |
|---|
| 2021-03-31 | Reported | -$4.63M | (m) | (m) | (m) | -14938.71% | $229.00K | -$5.63M | (m) | $2.75M | (m) | (m) |
|---|
| 2020-12-31 | Reported | -$6.12M | (m) | (m) | (m) | -19738.71% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-09-30 | Reported | -$2.70M* | -$2.75M | $45.00K* | $31.00K | -8722.58%* | $726.00K* | -$1.50M* | (m) | $1.81M | (m) | (m) |
|---|
| 2020-06-30 | Reported | (m) | -$2.62M | (m) | $31.00K | (m) | (m) | (m) | (m) | $1.79M | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | (m) | -$48.27M | (m) | (m) | (m) | $587.00K | -$38.31M | (m) | $30.50M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | (m) | -$33.37M | (m) | (m) | (m) | $16.00K | -$27.02M | (m) | $19.31M | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | (m) | -$38.39M | (m) | (m) | (m) | $457.00K | -$34.24M | (m) | $24.51M | (m) | $0.00 |
|---|
| 2022-12-31 | Reported | -$33.94M | (m) | (m) | (m) | -27155.20% | $1.30M | -$31.42M | (m) | $20.79M | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | -$25.49M | (m) | (m) | (m) | -20395.20% | $1.83M | -$22.22M | (m) | $15.18M | (m) | $0.00 |
|---|
| 2020-12-31 | Reported | -$13.72M | (m) | (m) | (m) | -10975.20% | $1.48M | -$9.07M | (m) | $8.75M | (m) | (m) |
|---|